[24 hour warning] These 7 stocks are reporting earnings very soon

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Is This The Most Overlooked Gold Investment Strategy of 2024?]( [Read this stunning report on a little-known gold royalty investment strategy]( --------------------------------------------------------------- November 22, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Gold Could Be Heading for Record Highs - But How to Play It?]( to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. [See this little-known way to play in the rising gold market.]( --------------------------------------------------------------- [PDD Holdings]( Symbol: [PDD]( Recent Price: $117.34 Average Analyst Price Target: $134.75 (6.98%) Market Cap: $152.99B Last Year's EPS: $1.01 Consensus EPS Forecast: $1.12 Expected Earnings Date: Nov 23 2023 Recent Analyst Action: Saiyi HE, analyst at CMB International Securities, reiterates coverage on [PDD Holdings (PDD)]( in the Consumer Cyclical sector with a Buy rating and a price target of n/a (6 days ago). [TipRanks.com]( also reports that [PDD Holdings]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $134.75 . The target pricing ranges from a high forecast of $155 down to a low forecast of $111. [PDD Holdings (PDD)](’s last closing price was $117.34 which would put the average price target at 6.98% upside. Here are 3rd party ratings for [PDD](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 22% (55 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Apple to SHOCK Emerging $46T Industry]( Valley venture capitalist Luke Lango says this little-known Apple project could be 10X bigger than the iPhone, MacBook, and iPad COMBINED! Investing in Apple today would be a smart move... but he’s discovered a bigger opportunity lying under Wall Street’s radar -one that could give early investors a shot at 40X gains! [Click here for more details.]( --------------------------------------------------------------- [Futu Holdings]( Symbol: [FUTU]( Recent Price: $60.37 Average Analyst Price Target: $63.01 (10.47%) Market Cap: $8.76B Last Year's EPS: $1.08 Consensus EPS Forecast: $6.89 Expected Earnings Date: Nov 23 2023 Recent Analyst Action: Katherine Lei, analyst at J.P. Morgan, reiterates coverage on [Futu Holdings (FUTU)]( in the Financial sector with a Hold rating and a price target of $60 (2 weeks ago). [TipRanks.com]( also reports that [Futu Holdings]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $63.01 . The target pricing ranges from a high forecast of $82 down to a low forecast of $44.25. [Futu Holdings (FUTU)](’s last closing price was $60.37 which would put the average price target at 10.47% upside. Here are 3rd party ratings for [FUTU](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 31% (79 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [H World Group]( Symbol: [HTHT]( Recent Price: $36.68 Average Analyst Price Target: $59.40 (46.86%) Market Cap: $11.28B Last Year's EPS: $0.44 Consensus EPS Forecast: $0.42 Expected Earnings Date: Nov 24 2023 Recent Analyst Action: Simon Cheung, analyst at Goldman Sachs, reiterates coverage on [H World Group (HTHT)]( in the Consumer Cyclical sector with a Buy rating and a price target of $50.6 (6 days ago). [TipRanks.com]( also reports that [H World Group]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $59.40 . The target pricing ranges from a high forecast of $64 down to a low forecast of $50.6. [H World Group (HTHT)](’s last closing price was $36.68 which would put the average price target at 46.86% upside. Here are 3rd party ratings for [HTHT](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 14% (34 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [GPT-4 vs. X.AI: The Race of the New AI Giants]( smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.]( --------------------------------------------------------------- [Can-Fite BioPharma]( Symbol: [CANF]( Recent Price: $2.14 Average Analyst Price Target: $36.67 (741.12%) Market Cap: $8.54M Last Year's EPS: -$0.65 Consensus EPS Forecast: -$0.54 Expected Earnings Date: Nov 24 2023 Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on [Can-Fite BioPharma (CANF)]( in the Healthcare sector with a Buy rating and a price target of $18 (4 weeks ago). [TipRanks.com]( also reports that [Can-Fite BioPharma]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $36.67 . The target pricing ranges from a high forecast of $80 down to a low forecast of $12. [Can-Fite BioPharma (CANF)](’s last closing price was $2.14 which would put the average price target at 741.12% upside. Here are 3rd party ratings for [CANF](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 26% (65 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Zscaler]( Symbol: [ZS]( Recent Price: $191.36 Average Analyst Price Target: $214.80 (0.19%) Market Cap: $27.59B Last Year's EPS: $0.37 Consensus EPS Forecast: $0.49 Expected Earnings Date: Nov 27 2023 Recent Analyst Action: Joseph Gallo, analyst at Jefferies, reiterates coverage on [Zscaler (ZS)]( in the Technology sector with a Buy rating and a price target of $225 (22 hours ago). [TipRanks.com]( also reports that [Zscaler]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $214.80 . The target pricing ranges from a high forecast of $225 down to a low forecast of $204. [Zscaler (ZS)](’s last closing price was $191.36 which would put the average price target at 0.19% upside. Here are 3rd party ratings for [ZS](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 33% (83 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold is about to SOAR – here’s what you need to do]( is lining up perfectly for a historic gold bull run. One gold research firm says they’ve found the best way to get in, for less than $5. --------------------------------------------------------------- [Cerence]( Symbol: [CRNC]( Recent Price: $16.84 Average Analyst Price Target: $30.67 (42.52%) Market Cap: $699.38M Last Year's EPS: -$0.04 Consensus EPS Forecast: -$0.15 Expected Earnings Date: Nov 27 2023 Recent Analyst Action: Jeff Van, analyst at Craig-Hallum, reiterates coverage on [Cerence (CRNC)]( in the Technology sector with a Buy rating (1 month ago). [TipRanks.com]( also reports that [Cerence]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $30.67 . The target pricing ranges from a high forecast of $42 down to a low forecast of $24. [Cerence (CRNC)](’s last closing price was $16.84 which would put the average price target at 42.52% upside. Here are 3rd party ratings for [CRNC](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 23% (58 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [OrganiGram Holdings]( Symbol: [OGI]( Recent Price: $1.23 Average Analyst Price Target: $2.97 (143.90%) Market Cap: $105.32M Last Year's EPS: -$0.08 Consensus EPS Forecast: -$0.05 Expected Earnings Date: Nov 27 2023 Recent Analyst Action: Neal Gilmer, analyst at Haywood, reiterates coverage on [OrganiGram Holdings (OGI)]( in the Healthcare sector with a Buy rating and a price target of $3 (2 weeks ago). [TipRanks.com]( also reports that [OrganiGram Holdings]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.97 . The target pricing ranges from a high forecast of $4.37 down to a low forecast of $1.64. [OrganiGram Holdings (OGI)](’s last closing price was $1.23 which would put the average price target at 143.90% upside. Here are 3rd party ratings for [OGI](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 45% (139 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is This "Royalty Strategy" the Most Overlooked Way to Play Gold?]( are catching on to a little-known strategy that has been quietly funding gold miners... This "royalty strategy" offers investors certain advantages over other gold vehicles, such as bullion, ETFs, and stocks. It provides investors exposure to rising gold prices and mining success - without all the operational risks and costs. [Read this startling report on a huge untapped opportunity]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software